Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure

By M. G. St. John Sutton, T. Plappert, W. Abraham, Andrew L. Smith, D. Delurgio, A. León, E. Loh, D. Kocovic, W. Fisher, M. Ellestad and 4 more. Circulation, 2003

1,173 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/5d811d28783a3558e34f293f434ca09d7a3b78b5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Gold
2. W. Abraham
3. S. Ghio
4. C. Daubert
5. M. G. St. John Sutton

Citations in the corpus

• Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. (2008, background): “Resynchronization herapy also progressively improves LV structure and funcion in these patients (6), raising the possibility that CRT ight delay disease progression in HF patients with less evere symptoms through LV reverse remodeling.”
• Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. (2012, neutral): “962 13 (13) [4/9] 14 (15) [5/9] 38 (39) [14/24] 41 (43) [15/26] 32 (33) [13/19] 31 (32) [11/20] 9 (9) [3/6] 7 (7) [3/4] 4 (4) [1/3] 4 (4) [1/3] 4 (4) [1/3] 3 (3) [0/3] 0.”